Table 4 Patients with a VTE episode > 12 months after initial diagnosis of AAV
From: Cytomegalovirus infection is a risk factor for venous thromboembolism in ANCA-associated vasculitis
Characteristic | All episodes n = 14 |
|---|---|
CMV seropositive | 14 (100%) |
Clinical relapse at time of VTE | 5 (36%) |
Infection requiring hospitalisation at time of VTE | 4 (29%) |
Malignancy at time of VTE | 3 (21%) |
Median creatinine at time of VTE in μmol/L (IQR) | 143 (110–188) |
Median CRP at time of VTE in mg/L | 42 (27–122) |
Median urine ACR at time of VTE mg/mmol (IQR) | 5 (1–8) |
Median serum albumin at time of VTE g/L (IQR) | 38 (33–46) |
Median serum Hb at time of VTE g/L (IQR) | 119 (93–126) |
Median time to VTE event in years (IQR) | 6.5 (3.4–13.0) |